DoD Gulf War Illness Innovative Treatment Evaluation Award

Funding Opportunity Number: W81XWH-13-GWIRP-ITEA Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementGrantCategory of Funding Activity: Science and Technology and other Research and DevelopmentCFDA Number: 12.420Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"Agency Name: DOD-AMRAAClosing Date: Sep 18, 2013Award Ceiling: $0Expected Number of Awards: 3Creation Date: May 14, 2013Funding Opportunity Description: The FY13 GWIRP is offering two award mechanisms to evaluate potential interventions for Gulf War Illness: the Innovative Treatment Evaluation Award (ITEA) and the Clinical Trial Award (CTA). The ITEA described in this Program Announcement/Funding Opportunity is intended to support the initial evaluation of a treatment or intervention in smaller, early phase or pilot clinical trials (Phase II or I/II, devices in U.S. Food and Drug Administration [FDA] Class I-III) and does not require preliminary data. In contrast, the FY13 GWIRP Clinical Trial Award supports the evaluation of interventions in larger, more definitive clinical trials (Phase II or III), where preliminary and preclinical evidence indicates the potential for substantial benefit for veterans with GWI. (For more information about the CTA, see http://cdmrp.army.mil/funding/gwirp.htm). The ITEA mechanism was first offered in FY...
Source: Grants.gov - Category: Research Tags: Science and Technology and other Research and Development Source Type: funding